| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/14/1992 | US5130232 ELISA kit for medical diagnosis, binding the monoclonal antibody, antigens and indicators |
| 07/14/1992 | US5130144 Human stem cells and monoclonal antibodies |
| 07/14/1992 | US5130129 Method for enhancing antibody transport through capillary barriers |
| 07/14/1992 | US5130128 Hyperimmunized against antigens found in honey |
| 07/12/1992 | WO1992012236A1 A NOVEL INTEGRIN β SUBUNIT AND USES THEREOF |
| 07/12/1992 | WO1992012235A1 FLAGELLA-LESS $i(BORRELIA) |
| 07/12/1992 | WO1992011870A1 Method of preventing inflammatory damage |
| 07/12/1992 | WO1992011853A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 07/12/1992 | CA2100352A1 Integrin .beta. subunit and uses thereof |
| 07/12/1992 | CA2100351A1 Amino-substituted pyrimidines, derivatives and methods of use therefor |
| 07/12/1992 | CA2100244A1 Flagella-less borrelia |
| 07/12/1992 | CA2100084A1 Method of preventing inflammatory damage |
| 07/11/1992 | WO1992012429A1 Highly sensitive assay of tissue factor and kit therefor |
| 07/11/1992 | CA2077906A1 Method for measurement of tissue factor in high sensitivity and measurement kit therefor |
| 07/10/1992 | WO1992012247A1 Analogs of piscine lhrh |
| 07/10/1992 | CA2100057A1 Analogs of piscine lhrh |
| 07/09/1992 | WO1992012243A1 New insulin-like growth factor binding protein (igfbp-6) |
| 07/09/1992 | WO1992011384A1 ANTIBODY AGAINST HUMAN PLASMIN-α2-PLASMIN INHIBITOR COMPLEX, HYBRIDOMA AND IMMUNOASSAY |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/09/1992 | WO1992011369A1 Hpv39 papillomavirus genome-derived dna sequences, their application to in vitro diagnosis and production of immunogenic compositions |
| 07/09/1992 | WO1992011367A2 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 07/09/1992 | WO1992011366A1 Cloning and expression of a protein antigen of toxoplasma gondii |
| 07/09/1992 | WO1992011365A1 Liver enriched transcription factor |
| 07/09/1992 | WO1992011293A1 Method for immobilization of thiol compounds via activation of polymers, activated polymers, and products obtained by the method |
| 07/09/1992 | WO1992011281A1 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 07/09/1992 | WO1992011031A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS |
| 07/09/1992 | WO1992011026A1 Neuronal cholinergic differentiation factor |
| 07/09/1992 | CA2100083A1 Insulin-like growth factor binding protein |
| 07/09/1992 | CA2098845A1 Cloning and expression of protein antigen of toxoplasma gondii |
| 07/09/1992 | CA2098733A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof |
| 07/08/1992 | EP0494085A1 Monoclonal antibodies binding determinants of gram negative bacteria |
| 07/08/1992 | EP0493686A1 Monoclonal antibodies to glycolipid carbohydrate chains |
| 07/08/1992 | EP0493533A1 Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
| 07/08/1992 | EP0493508A1 Novel peptides associated with the cd4 binding region of gp120 and their methods of use |
| 07/08/1992 | EP0493444A1 Blood-brain barrier model |
| 07/08/1992 | EP0493418A1 Method of producing fusion proteins. |
| 07/08/1992 | EP0487617A4 Synthetic peptides that enhance cell binding |
| 07/08/1992 | EP0448704A4 Osteogenic devices |
| 07/08/1992 | CN1017349B Monoclonal antibodies against atrial, natriuretic peptides of humans |
| 07/07/1992 | US5128453 Urinary follicle stimulating hormone |
| 07/07/1992 | US5128451 Protein V:AIgG binding factor |
| 07/07/1992 | US5128360 Method and agents for inhibiting protein aging |
| 07/07/1992 | US5128122 Nitrogen compound |
| 07/07/1992 | US5128119 Methods for technetium/rhenium labeling of f(ab1)2 fragments |
| 07/07/1992 | CA1304704C Production of interferon gamma |
| 07/07/1992 | CA1304681C Stable biologically active fluorochemical emulsions |
| 07/05/1992 | WO1992012262A1 Dna sequences related to isolated fragile x syndrome |
| 07/05/1992 | WO1992012169A1 Pseudomonas peptide composition and method for producing the same |
| 07/05/1992 | CA2094938A1 Dna sequences related to isolated fragile x syndrome |
| 07/02/1992 | DE4041114A1 IgG2a antibody fraction from body fluid of HIV patients - obtd. during latent phase of infection, deep frozen and re-administered, used for AIDS treatment |
| 07/01/1992 | EP0492560A2 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of HIV-1, and related peptides |
| 07/01/1992 | EP0492552A1 Anti-IGF-II monoclonal antibody |
| 07/01/1992 | EP0492530A1 Monoclonal antibodies which bind mannose binding protein |
| 07/01/1992 | EP0492525A2 Babesial protease antigen |
| 07/01/1992 | EP0492448A1 Monoclonal antibodies against human tumor necrosis factor alpha |
| 07/01/1992 | EP0492409A1 Human monoclonal antibody |
| 07/01/1992 | EP0492214A2 Human Interleukin-5 receptor |
| 07/01/1992 | EP0491888A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
| 07/01/1992 | EP0491867A1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer. |
| 07/01/1992 | EP0491859A1 TREPONEMA HYODYSENTERIAE ANTIGENS HAVING A MOLECULAR WEIGHT OF 39kDa AND DNA ENCODING THEREFOR |
| 07/01/1992 | EP0491858A1 Method and useful apparatus for preparing pharmaceutical compositions |
| 07/01/1992 | EP0491828A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF |
| 07/01/1992 | CA2058595A1 Acid-labile linker molecules |
| 06/30/1992 | US5126434 Monoclonal antibody specific for a human macrophage chemotactic factor |
| 06/30/1992 | US5126262 Monoclonal antibody |
| 06/30/1992 | US5126259 Human b. lymphoblastoid cell, hybridoma, antibody and production of antibody |
| 06/30/1992 | US5126258 Hydrolysis of polypeptides at predetermined site |
| 06/30/1992 | US5126250 Alteration of carboxy-terminal amino acid or acids from one or both of antibody heavy chains |
| 06/30/1992 | US5126240 Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i |
| 06/30/1992 | US5126130 Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a |
| 06/30/1992 | CA1304421C Affinity separating using immobilized flocculating reagents |
| 06/30/1992 | CA1304293C Immunoconjugates and methods for their use in tumor therapy |
| 06/30/1992 | CA1304288C Cell-free t cell antigen receptor and its clinical utilities |
| 06/28/1992 | CA2058003A1 Human-interleukin-5 receptor |
| 06/25/1992 | WO1992010756A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| 06/25/1992 | WO1992010591A1 Chimeric chains for receptor-associated signal transduction pathways |
| 06/25/1992 | WO1992010587A1 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 06/25/1992 | WO1992010583A1 G protein-coupled glutamate receptors |
| 06/25/1992 | WO1992010569A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine |
| 06/25/1992 | WO1992010520A1 Monoclonal antibody op-g2 and method of use |
| 06/25/1992 | WO1992010519A1 A novel protein tyrosine kinase |
| 06/25/1992 | WO1992010514A2 Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 06/25/1992 | WO1992010512A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/25/1992 | WO1992010511A1 Compounds and compositions which inhibit bone resorption |
| 06/25/1992 | WO1992010507A1 Site-specific conjugation of immunoglobulins and detectable labels |
| 06/25/1992 | WO1992010212A1 Anthracycline-conjugates |
| 06/25/1992 | WO1992010210A1 Inhibition of angiogenesis by il-1 |
| 06/25/1992 | WO1992010203A1 A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis |
| 06/25/1992 | WO1992010200A1 Functional interactions between glial s-100b and central nervous system serotonergic neurons |
| 06/25/1992 | WO1992010197A1 Substances of polypeptide nature useful in human therapy |
| 06/25/1992 | WO1992008731A3 T-cadherin adhesion molecule |
| 06/25/1992 | WO1992008474A3 Treatment of lung diseases |
| 06/25/1992 | DE4041059A1 New peptide for treating arthritis - contg. aminoacid sequence comprising epitope of fragment from human collagen |
| 06/25/1992 | CA2098188A1 Sperm cell surface protein ph-20 use in a contraceptive vaccine |
| 06/25/1992 | CA2097935A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| 06/25/1992 | CA2056118A1 Monoclonal antibodies which bind mannose binding protein |
| 06/24/1992 | EP0491675A1 Improvements relating to growth factors |
| 06/24/1992 | EP0491351A2 Chimeric antibodies and their use |
| 06/24/1992 | EP0491282A2 Pteridin derivatives, process for their preparation and their use in the preparation of immunogens |
| 06/24/1992 | EP0491057A1 Hybridoma which produces avian specific immunoglobulin g |